Latest period
172.48M
YoY change
+78.2%
5Y CAGR
+68.7%
Peak year (2025)
109.05M
Latest annual
109.05M
Shares Outstanding history chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: 109.05M
Shares Outstanding growth chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: +78.2%
Shares Outstanding history table for SELLAS Life Sciences Group (SLS) from 2006 to 2025
| 2025 | 109.05M | +78.2% | +47.85M | ||
| 2024 | 61.20M | +120.3% | +33.43M | ||
| 2023 | 27.78M | +43.2% | +8.38M | ||
| 2022 | 19.40M | +25.3% | +3.91M | ||
| 2021 | 15.48M | +94.1% | +7.50M | ||
| 2020 | 7.98M | +211.8% | +5.42M | ||
| 2019 | 2.56M | +878.3% | +2.30M | ||
| 2018 | 261,542 | +458.8% | +214,735 | ||
| 2017 | 46,807 | +147.0% | +27,859 | ||
| 2016 | 18,948 | -5.3% | -1,052 | ||
| 2015 | 20,000 | -44.2% | -15,811 | ||
| 2014 | 35,811 | +32.4% | +8,757 | ||
| 2013 | 27,054 | +44.4% | +8,316 | ||
| 2012 | 18,738 | +71.9% | +7,839 | ||
| 2011 | 10,899 | +97.9% | +5,391 | ||
| 2010 | 5,508 | +13.3% | +648 | ||
| 2009 | 4,860 | +17.9% | +738 | ||
| 2008 | 4,122 | +8.5% | +324 | ||
| 2007 | 3,798 | +0.5% | +18 | ||
| 2006 | 3,780 | — | — |
- 2025109.05M+78.2%
- 202461.20M+120.3%
- 202327.78M+43.2%
- 202219.40M+25.3%
- 202115.48M+94.1%
- 20207.98M+211.8%
- 20192.56M+878.3%
- 2018261,542+458.8%
- 201746,807+147.0%
- 201618,948-5.3%
- 201520,000-44.2%
- 201435,811+32.4%
- 201327,054+44.4%
- 201218,738+71.9%
- 201110,899+97.9%
- 20105,508+13.3%
- 20094,860+17.9%
- 20084,122+8.5%
- 20073,798+0.5%
- 20063,780—
Shares Outstanding values are taken from SELLAS Life Sciences Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at SELLAS Life Sciences Group (SLS)
According to SELLAS Life Sciences Group's latest reported financial statements, the company's latest reported diluted shares outstanding is 172.48M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
SELLAS Life Sciences Group (SLS) most recent annual diluted shares outstanding stands at 109.05M (2025) – surged 78.2% year-over-year.
SELLAS Life Sciences Group diluted shares outstanding has grown for 9 consecutive years, with a +68.7% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak diluted shares outstanding at 109.05M, with the historical low of 3,780 recorded in 2006.
SELLAS Life Sciences Group Shares Outstanding by Year
SELLAS Life Sciences Group Shares Outstanding 2025: 109.05M
SELLAS Life Sciences Group diluted shares outstanding in 2025 was 109.05M, surged 78.2% from 2024. This figure represents the highest annual value in the available history.
SELLAS Life Sciences Group Shares Outstanding 2024: 61.20M
2024's diluted shares outstanding for SELLAS Life Sciences Group came in at 61.20M, surged 120.3% from 2023.
SELLAS Life Sciences Group Shares Outstanding 2023: 27.78M
SELLAS Life Sciences Group posted diluted shares outstanding of 27.78M in 2023, surged 43.2% from 2022.
SELLAS Life Sciences Group Shares Outstanding 2022: 19.40M
In 2022, SELLAS Life Sciences Group reported diluted shares outstanding of 19.40M, grew 25.3% from 2021.
SELLAS Life Sciences Group Shares Outstanding 2021: 15.48M
SELLAS Life Sciences Group diluted shares outstanding in 2021 was 15.48M.
See more financial history for SELLAS Life Sciences Group (SLS).
Sector peers by Shares Outstanding
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation